Latest DTU publications
-
Cardiovascular outcomes with exenatide in type 2 diabetes according to ejection fraction: The EXSCEL trial.
Journal article
Neves JS. et al, (2024), Eur J Heart Fail
-
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
Journal article
Klonoff DC. et al, (2024), J Diabetes Sci Technol
-
Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial.
Journal article
Koychev I. et al, (2024), Alzheimers Res Ther, 16
-
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.
Journal article
Lugo-Palacios DG. et al, (2024), Health Econ
-
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Journal article
Schilling WHK. et al, (2024), PLoS Med, 21
-
Using QALYs as an outcome for assessing global prediction accuracy in diabetes simulation models
Journal article
DAKIN H. et al, (2024), Medical decision making
-
Estimated glomerular filtration rate slope and risk of primary and secondary major adverse cardiovascular events and heart failure hospitalization in people with type 2 diabetes: An analysis of the EXSCEL trial.
Journal article
Oulhaj A. et al, (2024), Diabetes Obes Metab
-
Examining the impact of structural uncertainty across ten type 2 diabetes models: Results from the 2022 Mount Hood Challenge.
Journal article
Altunkaya J. et al, (2024), Value Health
-
Estimating Risk Factor Time Paths Among People with Type 2 Diabetes and QALY Gains from Risk Factor Management
Journal article
Gao N. et al, (2024), PharmacoEconomics
-
Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults.
Journal article
Koychev I. et al, (2024), BMJ Open, 14
-
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Journal article
Adler AI. et al, (2024), Lancet
-
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data.
Journal article
Bidulka P. et al, (2024), BMJ, 385
-
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
Journal article
ROOPE L. et al, (2024), Communications Medicine
-
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 526 - 533
-
Are the cardiovascular properties of GLP-1 receptor agonists differentially modulated by sulfonylureas? insights from post-hoc analysis of EXSCEL.
Journal article
Gooding KM. et al, (2024), Diabetes Res Clin Pract
-
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity.
Journal article
Golubic R. et al, (2024), Diabetes Obes Metab
-
Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL.
Journal article
Rao VN. et al, (2024), Am Heart J, 271, 123 - 135
-
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.
Journal article
Morrow LM. et al, (2024), J Diabetes, 16
-
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology
-
Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.
Journal article
Chew Sue Mei S. et al, (2024), Endocrinology, diabetes & metabolism case reports, 2024, 23 - 133
About DTU
About DTU
Our People
Our Studies
CONTACT US
Phone: +44 (0)1865 857240
Email: dtu@dtu.ox.ac.uk